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This study evaluated the causes of false positive Human Immunodeficiency Virus test results (F+HIV), cross 
reactivity of HIV antibodies with other non HIV antibodies, and efficiency of the serial and parallel t sting 
algorithms. 100 blood samples randomly collected from clients attending the Heart to Heart HIV counseli g and 
testing unit of FMC Umuahia, were screened using the rapid ELISA and Enzyme Immuno Assay (EIA) tests. 
Discordant HIV results were screened for Anti Streptolycin O (ASO), Rheumatoid factor (RF) and Hepatitis B 
surface antigen (HBsAg). Of the 100 samples, 73 were n gative to HIV antibodies, 11 positive, and 16 discordant 
results. EIA confirmed 8 of 16 discordant results negative, 5 indeterminate and 3 positive. F+ results were 33%, and 
false negatives were 4%. A marked percentage of samples exhibited cross reactivity with ASO (8;62%), HBsAg 
(3;23%), and RF (2;15%). An Odds Ratio (OR) of 33:0 (95% CI 13.8-26.2), showed that Determine rapid test kit is 
33 times more likely to give a false positive HIV result than Unigold rapid test kit. The parallel algorithm showed 
better efficiency than the serial. This study showed that F+HIV test result is prevalent, and cross reactivity is the 
plausible cause of F+HIV test results.  
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Chronic infection with Human Immunodeficiency 
Virus (HIV) induces a progression of the depletion of 
CD4+ cells in individuals infected with the virus 
(Kashala et al., 1994). The resultant effect of this 
depletion is a weak immune system that gives room 
for opportunistic infections. Thus, early and correct 
diagnosis of the HIV virus is necessary to minimize 
the depletion of CD4+ cells.  
 
HIV screening tests and confirmation algorithms 
according to Walensky et al. (2008) are crucial 
because in this era of potent anti retroviral therapy, 
timely and correct diagnosis of HIV infection in the 
emergency wards and other testing sites are critical to 
ensure maximal treatment benefits. Walensky et al. 
(2008) reported that even highly accurate tests may
be reactive in the absence of disease, especially when 
prevalence of the disease is low; thereby giving rise 
to false positive results. This could create 
psychological as well as financial problems for 
patients.  
 
Wrong diagnosis has caused a lot of problems in 
diagnostic laboratories worldwide, and the 
psychological trauma that accompanies a wrong 
diagnosis cannot be quantified. The psychological 
trauma that accompanies wrong diagnosis was 
evident in the report of Dielenberg (2011) presented 
in The Star online news publication titled “Patient 
wrongly diagnosed with HIV awarded RM 150,000”. 
In the report, a father of five in Malaysia ran away to 
an unknown destination after a private hospital 
misdiagnosed him as HIV positive. Gardner (2010) 
noted that “trials have had problems recruiting peopl  
because of the stigma and repercussions” that 
accompanies a positive HIV test result. 
 
False-positives to HIV protein have been documented 
(Ng, 1991) and the rising cases of false positive HIV
(F+HIV) results with the ELISA, and indeterminate 
HIV results with the western blot assay has been 
linked to the reaction of HIV tests with many 
different diseases and conditions other than HIV 
(Cross-reactivity) (Treanor, 2006). Cross-reactivity is 
said to be a specific phenomenon in immunology and 
though cross-reacting antigens differ, they share 
common determinants and reaction is specific in 
respect to these determinants.  
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However, about 70-80% of the immunoglobulins 
produced by B-cells in response to an antigen are said 
to be non-specific (Koliadin, 1998). Proteins are 
renowned for their specificity of function. There is 
some evidence that many proteins, from enzymes to 
antibodies, are functionally confused and react 
indiscriminately (James and Tawfik, 2003). Cross- 
reaction occurs when an antibody directed against 
one protein, also reacts with another different proein 
against which that antibody is not directed (Jayapal, 
2007). Cross reactivity of antibodies is a very crucial 
one because the bane of wrong diagnosis partially 
depends on it. Hence, the possibility of cross 
reactivity and false positivity should be considered 
when testing for HIV antibodies. 
 
The national guidelines for HIV diagnosis is either a 
serial or a parallel algorithm. This is carried outwi h 
rapid diagnostic tests (RDTs), usually based on the 
ELISA technique. According to Shanks (2012), 
RDTs are screening tests not designed for definitive 
diagnosis, but very essential for blood transfusion 
screenings and emergency cases. RDTs are however, 
said to yield false positive results (Shanks, 2012). 
 
This study aims at evaluating the false positivity of 
HIV test results and cross reactivity of HIV 
antibodies with other non HIV antibodies, such as 
Anti Streptolysin O (ASO), Rheumatoid factor (RF) 
and Hepatitis B Surface Antigen (HBsAg), using 
rapid Determine HIV 1/2 test and Unigold test kit. 
Hence, this study shall evaluate the sensitivity and 
specificity of these test kits and determine the 
efficiencies of the parallel and serial testing 
algorithms. 
 
MATERIALS AND METHODS 
 
Study Area: The study was conducted at the Federal 
Medical Centre Umuahia, located in the State capital 
situated in Umuahia North Local Government Area 
of Abia State Nigeria. The Umuahia North local 
Government Area is bounded by Umuahia South, 
Aba North, Bende, and Okigwe Local Government 
Areas. The indigenous language is Igbo. 
 
Inclusion criteria:  Adult males and females of 18 
years and above attending the Heart to Heart HIV 
counseling and testing clinic at the time of the study, 
whose HIV statuses were not known, were recruited 
for this study. 
 
Exclusion criteria: Children below the age of 18 
years, pregnant women, confirmed cases of HIV, and 
clients who recently received any form of vaccination 
were excluded.  
Ethical consideration: Ethical approval was sought 
and granted by the Research and Ethics Committee of 
Federal Medical Centre Umuahia, while informed 
consent was obtained from willing participants. 
 
Duration of study: the study was conducted within a 
five week period (June/July, 2012). 
 
Study Design: Diagnostic test performance 
assessment within the framework of a cohort study.  
 
Sample size and method of sampling: Based on the 
estimated false positive HIV results of 7% (Shanks, 
2012) and the level of confidence (95%), the sample 
size was calculated to be 99.92 ≈ 100, using the 
formula n= t2х P(1-P) / m2 (UNICEF, 2005). [Where 
n= Desired sample size, t= Desired confidence level 
(95%) = 1.96., P= Estimated prevalence of false 
positive HIV test results, m = Degree of accuracy 
desired (Margin of error) (0.5% ie 0.05)] 
 
Hence, a sample size of 100 was used for the study. 
25 samples were collected the first week, 15 the 
second week, 20 the third week, 15 the fourth week, 
and 25 the fifth week. 
 
Sample collection: A total of 100 blood samples 
were randomly collected into serum separator 
vacutainer tubes from clients attending the Heart to 
Heart HIV Counseling and testing unit of the Federal 
Medical Center (FMC) Umuahia, Abia State, Nigeria, 
after obtaining informed consent. 2ml venous blood 
samples were drawn from each subject, and the 
samples serially labeled and allowed to cloth. The 
sera were then collected into clean sterile cryovials 
and stored in the refrigerator at 2-6 OC until samples 
were analyzed. 
 
Method of sample analysis: HIV testing was 
performed with Determine (Abbott Diagnostic 
Division, Netherlands) and Unigold (Trinity Biotech 
plc, Ireland) using the National guidelines (Serial and 
parallel Algorithms). Samples that gave discordant 
HIV screening results with the two kits were furthe 
subjected to Enzyme immunoassay (EIA) testing, to 
confirm the true sera-status of the samples using the 
Immuno-Comb 11 HIV 1&2 Comb-Firm kit 
(Orgenics). 
 
The samples that gave discordant results were also 
screened for ASO, RF and HBsAg. All assays were 
carried out as described by the manufacturers. The 
true sera-status of samples was established using the 
following algorithm: Samples reactive by EIA twice 
were considered positive while samples that were non 
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reactive by EIA twice were considered negative 
(FMOH, 2006). 
 
Data analysis: Statistical analysis was done using the 
Odds Ratio (OR) test to calculate the odds or 
likelihood of having a false positive result. The 
sensitivity and specificity analyses were determined 
to know the level of sensitivity and specificity of the 





Table 1 shows the HIV ELISA Screening Reaction 
by Determine and Unigold Test kits. While seventy 
three (73) samples reacted negative to HIV antibodies 
with both test kits, eleven (11) samples reacted 
positive with both kits. Thirteen (13) samples react d 
positive to HIV antibodies by Determine kit, but 
reacted negative by Unigold test kit while three (3) 
samples reacted positive to HIV by Unigold, but 
reacted negative by Determine. 
 
Table 2 shows the Confirmatory reactions for HIV 
discordant subjects and follow-up with ASO, RF and 
HBsAg screening tests. EIA confirmed the 73 
samples that reacted negative by both kits as 
negative. EIA confirmed 11 samples that reacted 
positive to both kits as positive. However, EIA 
confirmed 8 of the 16 discordant results as negative, 
5 as indeterminate, with only a single band positive 
for glycoprotein 120 (gp120) and 3 as positive. 
Table 3 shows the percentage representation of the 
sensitivity and specificity of the rapid test kits. The 
sensitivity and specificity of Determine were 84% 
and 90% respectively. While the sensitivity and 
specificity of Unigold was both 100% excluding the 
indeterminate cases. Percentage false positives with 
Determine test kit was 33%, and Percentage false 
negative was 4% 
 
Statistical test results showed the Odds ratio of 33:0 
indicating that Determine test kit is 33 times more 
likely to give a false positive result than Unigold. 
Also, determine is 33 times more likely to cross-react 
with non HIV antibodies than Unigold 
 
Figure 1 shows the cross reactivity of HIV antibodies 
with ASO, RF. and HBsAg.  Of the 16 discordant 
results, 8 (62%) samples reacted with ASO, 3 (23%) 
with HBsAg, and 2 (15%) with RF. However, the 3 
positive samples by Unigold, but negative by 
Determine were none reactive to these other tests. 
 
In this study, the 8 of the 13 discordant cases were 
considered to be false positives, and the 3 of the 76 
discordant considered false negatives. The 8 false-
positives (S20, S27, S30, S37, S44, S69, S75 and 
S93) had a positive reaction with ASO; 2 of the 5 
indeterminate (S 6 and S72) had a positive reaction 
with RF, while 3 of the indeterminate (S40, S52 and
S82) had a positive reaction with HBsAg. 
 
 
Table 1: HIV ELISA Screening Reaction with Determine and Unigold Test kits 
 ELISA Test  



























The results of this study has further confirmed that 
false positivity and cross reactivity in HIV 
investigation exist and hence a cause for concern that 
should be given attention. The 33% false positive 
results recorded in this study, though higher, are in 
accordance with the findings of Shanks (2012), who 
reported a false positive HIV result rate of 7% and 
the study of Scarano (2011) who reported a 0.2 
percent false positive HIV result with ELISA tests. 
Furthermore, Arora (2003) reported that various 
structural components of Streptococcus pyogenes 
exhibit antigenic cross reaction with different tissues 
International Journal of Community Research http://www.anrescentpub.com 
 ISSN: 2315 – 6562 
 
 Amechi et al.; Vol 1 (2): 54 – 59   57 
 
of the human body. Pregnancy, particularly multiple 
pregnancies and some disease conditions such as 
leprosy, malaria and tuberculosis have also been 
implicated in false positive HIV test results. 
  
Table 2:  Confirmatory reaction for HIV discordant subjects and follow-up with ASO, RF and HBsAg 
                                      






EIA (HIV 1&2 CombFirm) 
HIV 
Result 







P24 P31 gp120 gp41 gp36 HIV 
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Key : ASO = Antistreptolysin O Titre; RF = Rheumatoid factor; HBsAg = Hepatitis B surface antigen; -  = Non reactive; + = 
Reactive; Ind = Indeterminate; Pos= Positive; Neg= Negative; F+ve = False positive; F-ve = False negative. 
 









































Key: +ve = positive; -ve = negative; 
 
Scarano (2011) also reported in the article “Causes of 
a False Positive HIV Test” that Rethinkingaids.com 
noted a report by the American Medical Association, 
where in a preliminary health department data from 
August- November 1999; 32 pregnant women were 
diagnosed as HIV positive. However, a confirmatory 
test showed that 17 of the women were actually 
negative to the HIV virus. This is in accordance with 
our findings whereby of the 27 samples that reacted 
positive to HIV antibodies initially, only 14 were 
confirmed to be true positives. 
 
With the Odds Ratio of 33:0 (95% CI 13.8-26.2), it is 
evident that there is a good number of false positive 
HIV cases in the Umuahia metropolis of Nigeria. 
This result is not markedly different from that 
recorded by Walensky et al. (2008), where they 
recorded positive likelihood ratio of 8 to 32 with Ora 
Quick HIV screening test. In their Universal 
Screening for HIV infection in the Emergency Room 
(USHER) trial study in the emergency department 
with Ora Quick HIV test, of the 31 patients who 
initially tested positive to HIV antibodies, only five 
were found to be HIV-positive after undergoing a 
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confirmatory test to establish the true sero-status of 
the Ora-Quick tests. 
 
Cross reactivity with ASO, RF and HBsAg with HIV 
antibodies as observed in this study, resulting in false 
positive HIV result, corroborate the reports of 
Scarano (2011), where cross reactivity was observed 
in persons who had prior infections with hepatitis B, 
malaria or tuberculosis. Other persons, who had 
received flu vaccinations, had autoimmune diseases, 
and multiple pregnancies were also implicated in 
stimulating the production of antibodies that cross 
reacted with HIV antigens, thereby resulted in false 






Figure 1: Cross reactivity of HIV antibodies with ASO, RF.and HBsAg 
 
 
The sensitivity and specificity results of Unigold in 
this study met the expected results of the evaluation 
studies of Delaney et al. (2011), where sensitivity and 
specificity of Unigold was 100%. However, the 
sensitivity and specificity results of Determine did 
not meet the evaluation of 99.4% sensitivity and 
99.6% specificity recorded by van den Berk et al. 
(2003), but was rather lower than anticipated. This 
study showed that three positive reactions by Unigold 
test kit were not detected by determine test kit when 
the parallel algorithm was applied. This gave the 
parallel algorithm an edge over the serial because 
with the serial algorithm, the first line test 
(Determine) was negative. Going by the algorithm no 
further testing was required. 
 
In conclusion therefore, with the percentage of false 
positives and cross reactivity recorded in this study, it 
is advisable that medical diagnostic laboratories 
should not rely on a single HIV testing result, but a 
confirmatory test be carried out using antigen based 
testing kits to avoid litigations; as a fall out of false 
positive results as in the Negeswara case whereby the 
sum of RM 100,000 was awarded for medical 
negligence and Rm 50,000 for defamation when he 
was misdiagnosed of being HIV positive (Dielenberg, 
2011). In order to achieve this, it is recommended 
that a confirmation test be added to improve the test 
algorithm. Also, adding, and improving quality 
control, establishing an external quality control 
assessment scheme. Finally, quality assurance 
programs should be established to oversee the quality 
of tests results produced by the public and private 
sector to ensure that reliable and accurate results are 
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